March 9, 2026
Oral tolvaptan was superior to fluid restriction at raising plasma sodium concentration (pNa) in adults with hyponatremia, and those treated with tolvaptan who needed intravenous (IV) […]
March 9, 2026
TOPLINE: Adult patients with Cushing syndrome who completed a 22-week trial of relacorilant therapy and continued treatment for 12 additional weeks preserved hypertension control and sustained […]
March 6, 2026
Oral semaglutide led to significant reductions in the risk for heart failure and major adverse cardiac events (MACEs) among patients with type 2 diabetes (T2D) with […]
March 6, 2026
The US FDA has granted BioMarin Pharmaceutical Inc. approval for use of pegvaliase-pqpz (PALYNZIQ) for the treatment of phenylketonuria (PKU) in adolescents down to age 12 […]
March 5, 2026
TOPLINE: Lobectomy was associated with oncologic outcomes comparable to those of total thyroidectomy in patients with sporadic medullary thyroid cancer. Mortality, biochemical cure (serum calcitonin levels […]
March 5, 2026
TOPLINE: Compared with DPP-4 inhibitor therapy, sustained GLP-1 receptor agonist (GLP-1 RA) therapy was associated with greater short‑ and long‑term improvements in A1c levels and a […]
March 5, 2026
A collaborative physician/clinical pharmacist-led intervention for monitoring patients at a high risk for iatrogenic hypoglycemia significantly reduced the risk for severe diabetes medication-caused hypoglycemia without compromising […]
March 4, 2026
For women who have stopped menstruating due to anorexia and/or excessive exercise — a condition known as functional hypothalamic amenorrhea (FHA) — the use of transdermal […]
March 3, 2026
Giving patients a test for diabetes when they are in a dentist’s chair could help find more cases of the disease, academics have found. Estimates suggest […]